JQEZ5 manufacturers
- JQEZ5
-
- $46.00 / 5mg
-
2026-05-11
- CAS:1913252-04-6
- Min. Order:
- Purity: 99.93%
- Supply Ability: 10g
|
| Product Name: | JQEZ5 | | Synonyms: | JQEZ5;JQ-EZ-05;JQ-EZ-05 (JQEZ5);JQEZ5;JQE-Z5;JQE Z5;CS-2764;N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide;JQZ5;1H-Pyrazolo[3,4-b]pyridine-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]- | | CAS: | 1913252-04-6 | | MF: | C30H38N8O2 | | MW: | 542.68 | | EINECS: | | | Product Categories: | | | Mol File: | 1913252-04-6.mol |  |
| | JQEZ5 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:17.93(Max Conc. mg/mL);33.03(Max Conc. mM) | | form | A crystalline solid | | color | Light yellow to yellow |
| | JQEZ5 Usage And Synthesis |
| Uses | JQEZ5, is a novel and potent EZH2 inhibitor. | | in vivo | JQEZ5 (75 mg/kg; intraperitoneal injection; daily; for 3 weeks) treatment exhibits rapid and pronounced tumor regression over the three week treatment course. And H3K27me3 levels are largely reduced with treatment further confirming the on-target effect of JQEZ5 in mice[1]. | | IC 50 | EZH2 | | storage | Store at -20°C |
| | JQEZ5 Preparation Products And Raw materials |
|